The maker of the EpiPen will start selling a generic version in the wake of criticism about steep price increases. Mylan said it expected to start selling a cheaper generic product "in several weeks" at a list price of $300 (£230). That is about half the list price of the existing product, which i
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp